TY 2013 Form 990

(A) Name and business address	(B) Description of services	(C) Compensation
Josh Woods Production, 39 West 14th Street Suite 504NEW YORKNY10011	events production	425,200
AAB Productions, 64 allen street 5th floorNEW YORKNY10002	Events Production	338,942
The Morris King Company LLC, 101 Fifth Avenue 8th FloorNEW YORKNY10003	public relations	162,000
Stamp Event Management LLC, 247 Centre Street 7th FloorNEW YORKNY10013	Events Production	124,418
Global Health Institute, 5530 Wisconsin Avenue Suite 1255CHEVY CHASEMD20815	consulting	120,000
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 7

Do not include amounts reported on lines 6b, 7b, 8b, 9b, and 10b of Part VIII.	(A) Total expenses	(B) Program service expenses	(C) Management and general expenses	(D) Fundraising expenses
1	Grants and other assistance to governments and organizations in the United States. See Part IV, line 21	5,087,056	5,087,056
2	Grants and other assistance to individuals in the United States. See Part IV, line 22	0
3	Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16	4,841,328	4,841,328
4	Benefits paid to or for members	0
5	Compensation of current officers, directors, trustees, and key employees ....	2,289,885	1,661,237	305,219	323,429
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....	0
7	Other salaries and wages	5,300,415	3,564,555	578,582	1,157,278
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	312,266	212,168	38,939	61,159
9	Other employee benefits .......	1,196,548	775,429	175,700	245,419
10	Payroll taxes ...........	483,745	313,041	61,023	109,681
11	Fees for services (non-employees):
a	Management ......	0
b	Legal .........	142,109	113,795	22,025	6,289
c	Accounting ...........	206,660		206,660
d	Lobbying ...........	54,005	54,005
e	Professional fundraising services. See Part IV, line 17	569,004			569,004
f	Investment management fees ......	181,719		181,719
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) ........	1,902,283	1,373,365	55,077	473,841
12	Advertising and promotion ....	165,416	158,464	1,452	5,500
13	Office expenses .......	70,568	44,089	7,134	19,345
14	Information technology ......	206,908	146,402	27,883	32,623
15	Royalties ..	0
16	Occupancy ...........	1,283,349	886,297	164,549	232,503
17	Travel ............	1,193,970	654,496	4,914	534,560
18	Payments of travel or entertainment expenses for any federal, state, or local public officials ......	0
19	Conferences, conventions, and meetings ....	834,225	740,680	12,908	80,637
20	Interest ...........	59		59
21	Payments to affiliates .......	0
22	Depreciation, depletion, and amortization .....	324,970	224,998	41,773	58,199
23	Insurance ..............	251,444	174,091	32,322	45,031
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	PROGRAM MATERIALS	3,328,092	3,328,092
b	POSTAGE & SHIPPING	801,242	371,668	5,081	424,493
c	PROGRAM TECHNICAL SUPPORT	947,234	947,234
d	PRINTING	670,672	222,662	525	447,485
e	All other expenses	1,747,952	871,839	548,936	327,177
25	Total functional expenses. Add lines 1 through 24e	34,393,124	26,766,991	2,472,480	5,153,653
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).	1,012,168	380,896		631,272

Part X Balance Sheet Check if Schedule O contains a response or note to any line in this Part X ..............
	1	Cash–non-interest-bearing .............	8,001,602	1	4,961,745
2	Savings and temporary cash investments .........	539,347	2	323,338
3	Pledges and grants receivable, net ...........	205,706	3	0
4	Accounts receivable, net .............	10,267,012	4	5,045,656
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
		0	5	0
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
		0	6	0
7	Notes and loans receivable, net .............	0	7	0
8	Inventories for sale or use ..............	133,906	8	213,295
9	Prepaid expenses and deferred charges ..........	1,401,620	9	1,475,828
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	5,731,579
b	Less: accumulated depreciation .....	10b	3,500,879	1,975,311	10c	2,230,700
11	Investments—publicly traded securities ..........	23,656,458	11	40,982,916
12	Investments—other securities. See Part IV, line 11 .....	3,169,232	12	2,101,105
13	Investments—program-related. See Part IV, line 11 .....	0	13	0
14	Intangible assets ...............	0	14	0
15	Other assets. See Part IV, line 11 ...........	674,143	15	561,388
16	Total assets. Add lines 1 through 15 (must equal line 34)......	50,024,337	16	57,895,971
	17	Accounts payable and accrued expenses .........	1,688,090	17	2,132,495
18	Grants payable .................	2,200,512	18	2,547,120
19	Deferred revenue ................	13,321,993	19	7,166,426
20	Tax-exempt bond liabilities .............	0	20	0
21	Escrow or custodial account liability. Complete Part IV of Schedule D..	0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........	0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..	0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....	0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................	1,681,719	25	1,739,583
26	Total liabilities. Add lines 17 through 25.........	18,892,314	26	13,585,624
		Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............	23,555,115	27	38,819,754
28	Temporarily restricted net assets ...........	7,236,209	28	5,143,351
29	Permanently restricted net assets ...........	340,699	29	347,242
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........		30
31	Paid-in or capital surplus, or land, building or equipment fund .....		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	31,132,023	33	44,310,347
34	Total liabilities and net assets/fund balances ........	50,024,337	34	57,895,971

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.
right arrow

Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E.)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in

section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross

receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of

its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses

acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box that describes the type of supporting organization and complete lines 11e through 11h.

Type I

Type II

Type III - Functionally integrated

Type III - Non-functionally integrated

By checking this box, I certify that the organization is not controlled directly or indirectly by one or more disqualified persons other than foundation managers and other than one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2).

If the organization received a written determination from the IRS that it is a Type I, Type II, or Type III supporting organization, check this box ..................................................

Since August 17, 2006, has the organization accepted any gift or contribution from any of the
following persons?

(i) A person who directly or indirectly controls, either alone or together with persons described in (ii)

Yes

and (iii) below, the governing body of the supported organization? ................

11g(i)

(ii) A family member of a person described in (i) above? ......................

11g(ii)

(iii) A 35% controlled entity of a person described in (i) or (ii) above? ................

11g(iii)

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization in col. (i) listed in your governing document?		(v) Did you notify the organization in col. (i) of your support?		(vi) Is the organization in col. (i) organized in the U.S.?		(vii) Amount of monetary support
(i) Name of supported organization	(ii) EIN	Yes	No	Yes	No	Yes	No	(vii) Amount of monetary support


Total

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2013

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") ....	22,553,697	22,876,129	33,247,849	38,582,579	57,556,516	174,816,770
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......						0
3	The value of services or facilities furnished by a governmental unit to the organization without charge..						0
4	Total. Add lines 1 through 3	22,553,697	22,876,129	33,247,849	38,582,579	57,556,516	174,816,770
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						4,735,381
6	Public support. Subtract line 5 from line 4.						170,081,389

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
7	Amounts from line 4..	22,553,697	22,876,129	33,247,849	38,582,579	57,556,516	174,816,770
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	668,573	951,963	897,974	755,293	804,366	4,078,169
9	Net income from unrelated business activities, whether or not the business is regularly carried on..						0
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)..	2,756,152	1,735,330	1,624,966	1,467,184	1,693,403	9,277,035
11	Total support (Add lines 7 through 10).						188,171,974

Gross receipts from related activities, etc. (see instructions) ..................

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization, check this box and stop here................................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2013 (line 6, column (f) divided by line 11, column (f)) .........

90.386 %

Public support percentage for 2012 Schedule A, Part II, line 14 ...............

93.372 %

16a

33 1/3% support test—2013. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2012. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2013. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2012. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2013

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......
3	Gross receipts from activities that are not an unrelated trade or business under section 513..
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge..
6	Total. Add lines 1 through 5.
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons...
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2013 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2012 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2013 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2012 Schedule A, Part III, line 17 .............

19a

33 1/3% support tests—2013. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ........ right arrow

33 1/3% support tests—2012. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ..... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions ..... right arrow

Schedule A (Form 990 or 990-EZ) 2013

Page 4

Part IV

Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; and Part III, line 12. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Explanation

Schedule A (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

Information about Schedule B (Form 990, 990-EZ, or 990-PF) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, $5,000 or more (in money or
property) from any one contributor. Complete Parts I and II.

Special Rules

For a section 501(c)(3) organization filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi) and received from any one contributor, during the year, a contribution of the
greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 for use exclusively for religious, charitable,
scientific, literary, or educational purposes, or for the prevention of cruelty to children or animals. Complete Parts I, II, and
III.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions for use exclusively for religious, charitable, etc., purposes, but these contributions did
not total more than $1,000. If this box is checked, enter here the total contributions that were received during
the year for an exclusively religious, charitable, etc., purpose. Do not complete any of the parts unless the General Rule
applies to this organization because it received nonexclusively religious, charitable, etc., contributions of $5,000 or more
during the year ......................... Arrow Bullet

Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Page 2

Name of organization THE FOUNDATION FOR AIDS RESEARCH

Part I	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	RESTRICTED RESTRICTED RESTRICTED RESTRICTED, RESTRICTEDRESTRICTED	$RESTRICTED	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Page 3

Name of organization THE FOUNDATION FOR AIDS RESEARCH

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Page 4

Name of organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part III

Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet

$
Use duplicate copies of Part III if additional space is needed.

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

See separate instructions. SchCMd Bullet

Information about Schedule C (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

If the organization answered "Yes" to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" to Form 990, Part IV, Line 5 (Proxy Tax) or Form 990-EZ, Part V, line 35c (Proxy Tax), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV.

Political expenditures .................................... SchCMd Bullet

Volunteer hours ........................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ......... SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ...... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............

Yes No

Was a correction made? .........................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ................................... SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b.. SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ..........................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.

For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.

Cat. No. 50084S

Schedule C (Form 990 or 990-EZ) 2013

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......
b	Total lobbying expenditures to influence a legislative body (direct lobbying) .......
c	Total lobbying expenditures (add lines 1a and 1b) ...................
d	Other exempt purpose expenditures ........................
e	Total exempt purpose expenditures (add lines 1c and 1d) ...............
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ......................................	Yes No

4-Year Averaging Period Under Section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the instructions for lines 2a through 2f on page 4.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2010	(b) 2011	(c) 2012	(d) 2013	(e) Total

2a	Lobbying nontaxable amount

b	Lobbying ceiling amount (150% of line 2a, column(e))

c	Total lobbying expenditures

d	Grassroots nontaxable amount

e	Grassroots ceiling amount (150% of line 2d, column (e))

f	Grassroots lobbying expenditures

Schedule C (Form 990 or 990-EZ) 2013

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each "Yes" response to lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? .........................................

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....

Yes

Media advertisements? ....................................

Mailings to members, legislators, or the public? .........................

Publications, or published or broadcast statements? .......................

Grants to other organizations for lobbying purposes? .......................

Direct contact with legislators, their staffs, government officials, or a legislative body? ........

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......

Other activities? ..........................

Yes

179,298

Total. Add lines 1c through 1i ...............................

179,298

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 .................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ................

Did the organization agree to carry over lobbying and political expenditures from the prior year? ..........

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members .....................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).

Current year .........................................

Carryover from last year ....................................

Total ............................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................

Taxable amount of lobbying and political expenditures (see instructions) ..............

Part IV

Supplemental Information

Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, line 2; and Part ll-B, line 1. Also, complete this part for any additional information.

Return Reference	Explanation
Lobbying Expenses	Part II-B The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool.

Return Reference

Explanation

Lobbying Expenses

Part II-B The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool.

Schedule C (Form 990 or 990EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet

Attach to Form 990. SchDMd Bullet

See separate instructions. SchDMd Bullet

Information about Schedule D (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate contributions to (during year) ...
3	Aggregate grants from (during year) .....
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements .......................	2a
b	Total acreage restricted by conservation easements ..................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register ....................	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenues included in Form 990, Part VIII, line 1 ........................ SchDMd Bullet

(ii)

Assets included in Form 990, Part X .............................. SchDMd Bullet

$ 238,050

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenues included in Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2013

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other Donated Items, Inventory etc.

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No

If "Yes," explain the arrangement in Part XIII and complete the following table:


c	Beginning balance .................................	1c
d	Additions during the year ..............................	1d
e	Distributions during the year .............................	1e
f	Ending balance ...................................	1f

Did the organization include an amount on Form 990, Part X, line 21? .....................

Yes No

If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........

Part V

Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	b (c)Two years back	(d)Three years back	(e)Four years back
1a	Beginning of year balance ....	443,886	520,804	464,356	561,083	516,826
b	Contributions ........	6,543	3,211	4,341	5,978	8,258
c	Net investment earnings, gains, and losses	40,550	20,742	52,107	-2,705	35,999
d	Grants or scholarships .....
e	Other expenditures for facilities and programs ........		100,871		100,000
f	Administrative expenses ....
g	End of year balance ......	490,979	443,886	520,804	464,356	561,083

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

Permanent endowment SchDMd Bullet

70.724 %

Temporarily restricted endowment SchDMd Bullet

29.276 %

The percentages in lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations ........................

3a(i)

(ii) related organizations ........................

3a(ii)

If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11a. See Form 990, Part X, line 10.

Description of property		(b)Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value
1a	Land .................
b	Buildings ................
c	Leasehold improvements ............	2,210,687	757,960	1,452,727
d	Equipment ................	309,029	264,410	44,619
e	Other .................	3,211,863	2,478,509	733,354
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......				2,230,700

Schedule D (Form 990) 2013

Page 3

Part VII

InvestmentsOther Securities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11b. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)		(b)Book value	(c) Method of valuation: Cost or end-of-year market value
(1)Financial derivatives
(2)Closely-held equity interests
Other








Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

InvestmentsProgram Related. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11c. See Form 990, Part X, line 13.

(a) Description of investment		(b) Book value	(c) Method of valuation: Cost or end-of-year market value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11d. See Form 990, Part X, line 15.

(a) Description				(b) Book value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........

Part X

Other Liabilities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.

1.(a) Description of liability		(b) Book value
Federal income taxes		0
LONG TERM LEASE LIABILITY		1,526,258
SECTION 457 RETIREMENT LIABILITIES		213,325







Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)		1,739,583
2. Liability for uncertain tax positions In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII ..................................................

Schedule D (Form 990) 2013

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1	Total revenue, gains, and other support per audited financial statements .......			1	47,761,076
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains on investments ..........	2a	-295,064
b	Donated services and use of facilities .........	2b	189,628
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d	-33,603
e	Add lines 2a through 2d .....................			2e	-139,039
3	Subtract line 2e from line 1.....................			3	47,900,115
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b.......................			4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......			5	47,900,115

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1	Total expenses and losses per audited financial statements ...........			1	34,582,752
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities ..........	2a	189,628
b	Prior year adjustments ..............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d......................			2e	189,628
3	Subtract line 2e from line 1.....................			3	34,393,124
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.......................			4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......			5	34,393,124

Part XIII

Supplemental Information

Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Return Reference	Explanation
Endowments	Part V, Line 4 AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors.
FIN 48	Income taxes Amfar follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement, classification, interest and penalties, and disclosure. As of September 30, 2014, amfar does not believe that there are any uncertain tax positions within its financial statements. Amfar has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ended 2011, 2012, 2013, and 2014 are still open to audit for both federal and state purposes.
reconciliation of revenue	part XI, Line 2d change in value for third party trust ($33,603)
Collections of Art, Historical Treasures, or other similar assets	Part III, Line 4 AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them.

Schedule D (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

See separate instructions. Right pointing arrow large image

Information about Schedule F (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.

For grantmakers.Does the organization maintain records to substantiate the amount of its grants and

other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used

to award the grants or assistance? ...............................

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(b) Number of offices in the region	(c) Number of employees, agents, and independent contractors in region	(d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in region	(f) Total expenditures for and investments in region
	Central America and the Caribbean			Grantmaking	N/A	74,955
	East Asia and the Pacific	1	19	Program Services	THERAPEUTICS RESEARCH	2,186,834
	Europe (Including Iceland and Greenland)			Fundraising	n/a	14,863,143
	North America			Grantmaking	n/a	266,518
	Russia and the Newly Independent States			Grantmaking	n/a	25,000
	South America			Fundraising	n/a	1,687,171
	South Asia			Fundraising	n/a	1,044,280
	Sub-Saharan Africa			Grantmaking	n/a	254,310
	East Asia and the Pacific			Grantmaking	n/a	3,063,980
	Europe (Including Iceland and Greenland)			Grantmaking	n/a	824,303
	North America			Fundraising	n/a	1,791
	South America			Grantmaking	n/a	189,805
	South Asia			Grantmaking	n/a	142,457




3a	Sub-total .....	1	19			24,624,547
b	Total from continuation sheets to Part I ...
c	Totals (add lines 3a and 3b)	1	19			24,624,547

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2013

Schedule F (Form 990) 2013

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(d) Purpose of grant	(e) Amount of cash grant	(f) Manner of cash disbursement
Caribbean/Central America	GMT INITIATIVES	10,000	wire transfe
Caribbean/Central America	GMT INITIATIVES	19,955	wire transfe
Caribbean/Central America	GMT INITIATIVES	20,000	wire transfe
Caribbean/Central America	GMT INITIATIVES	25,000	wire transfe
East Asia/Pacific	TREAT ASIA	5,050	wire transfe
East Asia/Pacific	TREAT ASIA	5,175	wire transfe
East Asia/Pacific	TREAT ASIA	5,175	wire transfe
East Asia/Pacific	TREAT ASIA	5,250	wire transfe
East Asia/Pacific	TREAT ASIA	5,625	wire transfe
East Asia/Pacific	TREAT ASIA	5,625	wire transfe
East Asia/Pacific	TREAT ASIA	5,625	wire transfe
East Asia/Pacific	TREAT ASIA	5,625	wire transfe
East Asia/Pacific	TREAT ASIA	5,625	wire transfe
East Asia/Pacific	TREAT ASIA	5,845	wire transfe
East Asia/Pacific	TREAT ASIA	5,915	wire transfe
East Asia/Pacific	TREAT ASIA	5,948	wire transfe
East Asia/Pacific	TREAT ASIA	5,990	wire transfe
East Asia/Pacific	TREAT ASIA	6,000	wire transfe
East Asia/Pacific	TREAT ASIA	6,075	wire transfe
East Asia/Pacific	TREAT ASIA	6,600	wire transfe
East Asia/Pacific	TREAT ASIA	6,700	wire transfe
East Asia/Pacific	TREAT ASIA	6,825	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,545	wire transfe
East Asia/Pacific	TREAT ASIA	7,865	wire transfe
East Asia/Pacific	TREAT ASIA	7,898	wire transfe
East Asia/Pacific	TREAT ASIA	8,000	wire transfe
East Asia/Pacific	TREAT ASIA	8,135	wire transfe
East Asia/Pacific	TREAT ASIA	8,500	wire transfe
East Asia/Pacific	TREAT ASIA	8,960	wire transfe
East Asia/Pacific	TREAT ASIA	9,253	wire transfe
East Asia/Pacific	TREAT ASIA	9,383	wire transfe
East Asia/Pacific	TREAT ASIA	11,250	wire transfe
East Asia/Pacific	TREAT ASIA	11,250	wire transfe
East Asia/Pacific	TREAT ASIA	11,250	wire transfe
East Asia/Pacific	TREAT ASIA	11,787	wire transfe
East Asia/Pacific	TREAT ASIA	12,020	wire transfe
East Asia/Pacific	TREAT ASIA	12,220	wire transfe
East Asia/Pacific	TREAT ASIA	12,500	wire transfe
East Asia/Pacific	TREAT ASIA	12,510	wire transfe
East Asia/Pacific	TREAT ASIA	12,900	wire transfe
East Asia/Pacific	TREAT ASIA	13,270	wire transfe
East Asia/Pacific	TREAT ASIA	13,500	wire transfe
East Asia/Pacific	TREAT ASIA	13,500	wire transfe
East Asia/Pacific	TREAT ASIA	13,593	wire transfe
East Asia/Pacific	TREAT ASIA	14,850	wire transfe
East Asia/Pacific	TREAT ASIA	14,873	wire transfe
East Asia/Pacific	TREAT ASIA	15,000	wire transfe
East Asia/Pacific	TREAT ASIA	15,065	wire transfe
East Asia/Pacific	TREAT ASIA	15,100	wire transfe
East Asia/Pacific	TREAT ASIA	15,150	wire transfe
East Asia/Pacific	TREAT ASIA	15,500	wire transfe
East Asia/Pacific	TREAT ASIA	15,600	wire transfe
East Asia/Pacific	TREAT ASIA	15,830	wire transfe
East Asia/Pacific	TREAT ASIA	17,330	wire transfe
East Asia/Pacific	TREAT ASIA	18,486	wire transfe
East Asia/Pacific	TREAT ASIA	18,750	wire transfe
East Asia/Pacific	TREAT ASIA	19,150	wire transfe
East Asia/Pacific	TREAT ASIA	19,200	wire transfe
East Asia/Pacific	TREAT ASIA	19,574	wire transfe
East Asia/Pacific	TREAT ASIA	19,780	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	20,923	wire transfe
East Asia/Pacific	GMT INITIATIVES	25,000	wire transfe
East Asia/Pacific	GMT INITIATIVES	25,000	wire transfe
East Asia/Pacific	GMT INITIATIVES	25,000	wire transfe
East Asia/Pacific	TREAT ASIA	25,000	wire transfe
East Asia/Pacific	TREAT ASIA	25,200	wire transfe
East Asia/Pacific	TREAT ASIA	26,850	wire transfe
East Asia/Pacific	TREAT ASIA	29,515	wire transfe
East Asia/Pacific	TREAT ASIA	30,024	wire transfe
East Asia/Pacific	TREAT ASIA	31,388	wire transfe
East Asia/Pacific	TREAT ASIA	32,175	wire transfe
East Asia/Pacific	TREAT ASIA	32,515	wire transfe
East Asia/Pacific	TREAT ASIA	33,010	wire transfe
East Asia/Pacific	TREAT ASIA	33,010	wire transfe
East Asia/Pacific	TREAT ASIA	34,010	wire transfe
East Asia/Pacific	TREAT ASIA	34,035	wire transfe
East Asia/Pacific	TREAT ASIA	35,000	wire transfe
East Asia/Pacific	TREAT ASIA	35,000	wire transfe
East Asia/Pacific	TREAT ASIA	41,158	wire transfe
East Asia/Pacific	TREAT ASIA	46,905	wire transfe
East Asia/Pacific	GMT INITIATIVES	50,000	wire transfe
East Asia/Pacific	TREAT ASIA	50,000	wire transfe
East Asia/Pacific	TREAT ASIA	54,000	wire transfe
East Asia/Pacific	TREAT ASIA	57,276	wire transfe
East Asia/Pacific	TREAT ASIA	75,579	wire transfe
East Asia/Pacific	TREAT ASIA	75,717	wire transfe
East Asia/Pacific	TREAT ASIA	77,250	wire transfe
East Asia/Pacific	TREAT ASIA	95,000	wire transfe
East Asia/Pacific	TREAT ASIA	104,839	wire transfe
East Asia/Pacific	TREAT ASIA	110,570	wire transfe
East Asia/Pacific	BASIC RESEARCH	120,000	wire transfe
East Asia/Pacific	TREAT ASIA	192,418	wire transfe
East Asia/Pacific	TREAT ASIA	221,907	wire transfe
East Asia/Pacific	TREAT ASIA	227,908	wire transfe
East Asia/Pacific	TREAT ASIA	232,676	wire transfe
Europe	BASIC RESEARCH	39,066	wire transfe
Europe	PUBLIC POLICY	39,948	wire transfe
Europe	PUBLIC POLICY	50,000	wire transfe
Europe	BASIC RESEARCH	60,000	wire transfe
Europe	BASIC RESEARCH	60,000	wire transfe
Europe	BASIC RESEARCH	75,000	wire transfe
Europe	BASIC RESEARCH	75,000	wire transfe
Europe	BASIC RESEARCH	75,635	wire transfe
Europe	BASIC RESEARCH	81,852	wire transfe
Europe	BASIC RESEARCH	120,000	wire transfe
Europe	BASIC RESEARCH	147,802	wire transfe
North America (excl USA)	GMT INITIATIVES	18,000	wire transfe
North America (excl USA)	BASIC RESEARCH	118,518	wire transfe
North America (excl USA)	PREVENTION SCIENCE OUTREACH	130,000	wire transfe
Russia/Newly Independent States	GMT INITIATIVES	25,000	wire transfe
South America	GMT INITIATIVES	19,885	wire transfe
South America	GMT INITIATIVES	19,940	wire transfe
South America	GMT INITIATIVES	19,980	wire transfe
South America	GMT INITIATIVES	20,000	wire transfe
South America	GMT INITIATIVES	20,000	wire transfe
South America	GMT INITIATIVES	20,000	wire transfe
South America	PREVENTION SCIENCE OUTREACH	20,000	wire transfe
South America	PREVENTION SCIENCE OUTREACH	50,000	wire transfe
South Asia	TREAT ASIA	5,625	wire transfe
South Asia	TREAT ASIA	7,500	wire transfe
South Asia	TREAT ASIA	8,000	wire transfe
South Asia	TREAT ASIA	11,793	wire transfe
South Asia	TREAT ASIA	19,400	wire transfe
South Asia	TREAT ASIA	19,542	wire transfe
South Asia	TREAT ASIA	20,000	wire transfe
South Asia	TREAT ASIA	31,631	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	12,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	12,310	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	20,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	25,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	25,000	wire transfe
Sub-Saharan Africa	GMT INITIATIVES	25,000	wire transfe
Sub-Saharan Africa	PUBLIC POLICY	25,000	wire transfe

Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .... MediumBullet

149

Enter total number of other organizations or entities ....................... MediumBullet

Schedule F (Form 990) 2013

Schedule F (Form 990) 2013Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of non-cash assistance	(g) Description of non-cash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2013

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2013

Page 5

Part V

Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).

ReturnReference	Explanation
Foreign Activities	Part I, Line 2 International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period.
foreign activities	Part I, Line 3, Column D The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives.
Foreign Activities - Status of Grantees	The Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 149 charities supported are presumed to be the equivalent of U.S. charities.

Schedule F (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE G (Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information Regarding
Fundraising or Gaming Activities

Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrow

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.
right arrow

Information about Schedule G (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.

Form 990-EZ filers are not required to complete this part.

Indicate whether the organization raised funds through any of the following activities. Check all that apply.

a	Mail solicitations	e	Solicitation of non-government grants
b	Internet and email solicitations	f	Solicitation of government grants
c	Phone solicitations	g	Special fundraising events
d	In-person solicitations

Did the organization have a written or oral agreement with any individual (including officers, directors, trustees

or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?

Yes

If "Yes," list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.

(i) Name and address of individual or entity (fundraiser)		(ii) Activity	(iii) Did fundraiser have custody or control of contributions?		(iv) Gross receipts from activity	(v) Amount paid to (or retained by) fundraiser listed in col. (i)	(vi) Amount paid to (or retained by) organization
			Yes	No
	aab productions 387 GRANT STREET SUITE K705 NEW YORK, NY10002	events production		No	31,238,437	555,619	30,682,818
	EIDOLON COMMUNICATIONS INC 15 MAIDEN LANE SUITE 1401 NEW YORK, NY10038	direct mail		No	2,023,625	228,493	1,795,132
	public interest communications 7700 LEESBURG PIKE FALLS CHURCH, VA22043	tele marketing		No	14,927	39,032	-24,105
	SANKY COMMUNICATIONS INC 589 EIGHT AVENUE 10TH FLOOR NEW YORK, NY10018	TELE MARKETING		No	353,939	57,810	296,129






Total .................					33,630,928	880,954	32,749,974

List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.

AL, AK, AR, CA, CO, CT, DC, FL, GA, HI, IL, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WV, WI

For Paperwork Reduction Act Notice, see the Instructions for Form 990or 990-EZ.

Cat. No. 50083H

Schedule G (Form 990 or 990-EZ) 2013

Page 2

Part II

Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.

		(a) Event #1 CANNES (event type)	(b) Event #2 DALLAS (event type)	(c) Other events 17 (total number)	(d) Total events (add col. (a) through col. (c))
1	Gross receipts . . .	24,869,711	3,074,959	13,442,056	41,386,726
2	Less: Contributions . .	24,424,711	2,966,759	12,546,391	39,937,861
3	Gross income (line 1 minus line 2) . . .	445,000	108,200	895,665	1,448,865
4	Cash prizes . . .
5	Noncash prizes . .
6	Rent/facility costs . .	1,333,994	283,704	348,100	1,965,798
7	Food and beverages .	238,238	178,033	641,481	1,057,752
8	Entertainment . . .	1,218,319	84,797	1,804,451	3,107,567
9	Other direct expenses .	3,748,981	481,108	2,278,239	6,508,328
10	Direct expense summary. Add lines 4 through 9 in column (d) ...........				12,639,445
11	Net income summary. Subtract line 10 from line 3, column (d)...........				-11,190,580

Part III

Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.

(a) Bingo

(b) Pull tabs/Instant
bingo/progressive bingo

(c) Other gaming

(d) Total gaming (add col.(a) through col.(c))

Gross revenue . . . .

Cash prizes . . . .

Non-cash prizes . . .

Rent/facility costs . . .

Other direct expenses . .

Volunteer labor . . .

	Yes %
	No

	Yes %
	No

	Yes %
	No

Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow

Net gaming income summary. Subtract line 7 from line 1, column (d) ......... right arrow

Enter the state(s) in which the organization operates gaming activities:

Is the organization licensed to operate gaming activities in each of these states? ............

YesNo

If "No," explain:

10a

Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....

YesNo

If "Yes," explain:

Schedule G (Form 990 or 990-EZ) 2013

Page 3

Does the organization operate gaming activities with nonmembers? .................

YesNo

Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity

formed to administer charitable gaming? ..........................

YesNo

Indicate the percentage of gaming activity operated in:

The organization's facility ......................

13a

An outside facility ........................

13b

Enter the name and address of the person who prepares the organization's gaming/special events books and records:

Name

Address

15a

Does the organization have a contract with a third party from whom the organization receives gaming

revenue? ......................................

YesNo

If "Yes," enter the amount of gaming revenue received by the organization right arrow

$ and the

amount of gaming revenue retained by the third party right arrow

$ .

If "Yes," enter name and address of the third party:

Name

Address

Gaming manager information:

Name

Gaming manager compensation right arrow

Description of services provided right arrow

Director/officer Employee Independent contractor

Mandatory distributions:

Is the organization required under state law to make charitable distributions from the gaming proceeds to

retain the state gaming license? ............................

YesNo

Enter the amount of distributions required under state law distributed to other exempt organizations or spent

in the organization's own exempt activities during the tax year right arrow

Part IV

Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v), and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also complete this part to provide any additional information (see instructions).

Return Reference

Explanation

Schedule G, Part I

The Foundation for AIDS Research actually paid out $569,004 in fundraising expenses for the year ending September 30, 2014. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $880,954. Of that $880,954, only $569,004 was paid for fundraising services, the remaining $311,950 was paid for event production services. In the interests of clarity, the foundation would also like to make clear that the compensation reported as having been paid to the professional fundraisers reported on Schedule G is reported on a fiscal year basis. Some of those same fundraisers are reported on the foundation's top 5 highest paid independent contractors list (in Schedule O). In compliance with the instructions to the Form 990, compensation reported for Part VII (and listed in Schedule O) is reported on a calendar year basis. Accordingly, amounts on Part VII and Schedule G will not reconcile.

Schedule G (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990
lBullet

Information about Schedule I (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number
13-3163817

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC Code section if applicable	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) Vaccine & Gene Therapy Institute of Florida 11350 SW Village Pkwy Pt St Lucie,FL34987	36-4631835	501(c)(3)	5,209	BASIC RESEARCH
(2) University of Washington 4333 Brooklyn Avenue Seattle,WA981959472	91-6001537	501(c)(3)	5,209	BASIC RESEARCH
(3) Vaccine & Gene Therapy Institute of Florida 11350 SW Village Pkwy Pt St Lucie,FL34987	36-4631835	501(c)(3)	5,209	BASIC RESEARCH
(4) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	5,209	BASIC RESEARCH
(5) AIDS Foundation of Chicago 200 West Jackson Ste 2200 Chicago,IL60606	36-3412054	501(c)(3)	10,000	MSM INITIATIVES
(6) AIDS Project Los Angeles (APLA) 611 S Kingsley Drive Los Angeles,CA90005	95-3842506	501(c)(3)	10,000	MSM INITIATIVES
(7) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	15,620	BASIC RESEARCH
(8) Aaron Diamond AIDS Research Center 455 1st Ave 7th Fl New York,NY10016	13-3540234	501(c)(3)	15,626	BASIC RESEARCH
(9) New England Primate Research Center Harvard Medical School 25 Shattuck Southborough,MA01772	04-2103580	501(c)(3)	15,626	BASIC RESEARCH
(10) AIDS Resource Center Ohio 15 W 4th St No 200 Dayton,OH45402	31-1126780	501(c)(3)	20,000	PUBLIC POLICY
(11) AIDS Foundation of Chicago 200 W Jackson Ste 2200 Chicago,IL60606	36-3412054	501(c)(3)	20,000	PUBLIC POLICY
(12) Baron Edmond de Rothschild Chemical Dep 1st Ave at 16th St New York,NY10003	13-5564930	501(c)(3)	22,500	PUBLIC POLICY
(13) John Hopkins University 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	26,458	TREAT ASIA
(14) California Institute of Technology 1200 E California Blvd Pasadena,CA91125	95-1643307	501(c)(3)	41,600	BASIC RESEARCH
(15) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501(c)(3)	41,666	BASIC RESEARCH
(16) Massachusetts General Hospital 55 Fruit Street Boston,MA02114	04-2697983	501(c)(3)	41,666	BASIC RESEARCH
(17) The University of North Carolina at Chapel Hill 104 Airport Dr Chapel Hill,NC27599	56-6001393	501(c)(3)	43,754	BASIC RESEARCH
(18) Emory University 1599 Clifton Rd Atlanta,GA303224250	58-0566256	501(c)(3)	45,000	BASIC RESEARCH
(19) John Hopkins University 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	45,571	MSM INITIATIVES
(20) Research Foundation for Mental Hygiene Inc 1015 Riverside Drive New York,NY10032	14-1410842	501(c)(3)	50,000	MSM INITIATIVES
(21) Black AIDS Institute 1833 West 8th St Los Angeles,CA90057	95-4742741	501(c)(3)	50,000	PUBLIC POLICY
(22) Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston,MA02215	04-2103881	501(c)(3)	50,361	BASIC RESEARCH
(23) New Hope for Cambodian Children PO Box 2490 Killeen,TX76549	20-5301015	501(c)(3)	53,790	TREAT ASIA
(24) Harvard Medical School 25 Shattuck Street Southborough,MA01772	04-2697981	501(c)(3)	59,600	BASIC RESEARCH
(25) Vaccine & Gene Therapy Institute of Florida 9801 SW Discovery Way Pt St Lucie,FL34987	36-4631835	501(c)(3)	59,994	BASIC RESEARCH
(26) John Hopkins University School of Medicine 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	59,999	BASIC RESEARCH
(27) Veterans Medical Research Foundation 3350 La Jolla Village Drive mc 151 San Diego,CA92161	33-0189397	501(c)(3)	60,000	BASIC RESEARCH
(28) University of Washington 4333 Brooklyn Ave NE Seattle,WA98195	91-6001537	501(c)(3)	60,000	BASIC RESEARCH
(29) Fred Hutchinson Cancer Research Center 1100 Fairview Ave N Seattle,WA98109	23-7156071	501(c)(3)	62,502	BASIC RESEARCH
(30) Dana-Farber Cancer Institute Inc 450 Brookline Ave Boston,MA02215	04-2263040	501(c)(3)	62,502	BASIC RESEARCH
(31) The Scripps Research Institute 10550 N Torrey Pines Rd La Jolla,CA92037	33-0435954	501(c)(3)	62,502	BASIC RESEARCH
(32) Colorado State University 408 Uni Svcs Ctr Fort Collins,CO80523	84-6000545	501(c)(3)	62,709	BASIC RESEARCH
(33) Oregon Health and Science University 3181 SW Sam Jackson rd Portland,OR97239	19-3176109	501(c)(3)	66,527	BASIC RESEARCH
(34) Mount Sinai Beth Israel 1st Ave at 16th St New York,NY10003	13-5564934	501(c)(3)	67,500	PUBLIC POLICY
(35) Vaccine & Gene Therapy Institute of Florida 9801 SW Discovery Way Pt St Lucie,FL34987	36-4631835	501(c)(3)	74,940	BASIC RESEARCH
(36) Emory University 954 Gatewood Road NE Atlanta,GA30329	58-0566256	501(c)(3)	75,000	BASIC RESEARCH
(37) Massachusetts General Hospital 55 Fruit Street Boston,MA02114	04-2697983	501(c)(3)	75,000	BASIC RESEARCH
(38) The University of North Carolina at Chapel Hill 104 Airport Dr Chapel Hill,NC27599	56-6001393	501(c)(3)	75,000	BASIC RESEARCH
(39) University of California Los Angeles 11000 Kinross Ave Los Angeles,CA90095	95-6006143	501(c)(3)	75,000	BASIC RESEARCH
(40) University of Southern California 2001 North Soto St Los Angeles,CA90089	95-1642394	501(c)(3)	90,000	BASIC RESEARCH
(41) Emory University 1599 Clifton Rd Atlanta,GA303224250	58-0566256	501(c)(3)	90,000	BASIC RESEARCH
(42) Icahn School of Medicine at Mount Sinai One Gustave Levy Place New York,NY10029	13-6171197	501(c)(3)	90,000	BASIC RESEARCH
(43) John Hopkins University 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	90,000	BASIC RESEARCH
(44) John Hopkins University 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	117,555	BASIC RESEARCH
(45) Oregon Health and Science University 3181 SW Sam Jackson Rd Portland,OR97239	93-1176109	501(c)(3)	119,864	BASIC RESEARCH
(46) Vaccine & Gene Therapy Institute of Florida 9801 SW Discovery Way Pt St Lucie,FL34987	36-4631835	501(c)(3)	119,957	BASIC RESEARCH
(47) Oregon Health and Science University 3181 SW Sam Jackson Rd Portland,OR97239	93-1176109	501(c)(3)	119,994	BASIC RESEARCH
(48) John Hopkins University 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	120,000	BASIC RESEARCH
(49) Vaccine & Gene Therapy Institute of Florida 9801 SW Discovery Way Pt St Lucie,FL34987	36-4631835	501(c)(3)	120,000	BASIC RESEARCH
(50) Northwestern Unversity 303 E Superior St Chicago,IL60611	36-2167817	501(c)(3)	120,000	BASIC RESEARCH
(51) Regents of the University of California 3333 California St San Francisco,CA94143	94-6036493	501(c)(3)	120,000	BASIC RESEARCH
(52) John Hopkins University 733 N Broadway Baltimore,MD21205	52-0595110	501(c)(3)	120,000	BASIC RESEARCH
(53) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	120,000	BASIC RESEARCH
(54) Blood Systems Inc 270 Masonic Ave San Francisco,CA94118	86-0098929	501(c)(3)	126,580	BASIC RESEARCH
(55) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	140,507	BASIC RESEARCH
(56) Vaccine & Gene Therapy Institute of Florida 9801 SW Discovery Way Pt St Lucie,FL34987	36-4631835	501(c)(3)	146,029	BASIC RESEARCH
(57) University of Pittsburgh 123 University Place Pittsburgh,PA15213	25-0965591	501(c)(3)	167,804	MSM INITIATIVES
(58) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	185,130	BASIC RESEARCH
(59) The Brigham and Women's Hospital Inc 75 Francis Street Boston,MA02115	04-2312909	501(c)(3)	191,039	BASIC RESEARCH
(60) University of California Los Angeles 11000 Kinross Ave Los Angeles,CA90095	95-6006143	501(c)(3)	200,000	BASIC RESEARCH
(61) Massachusetts General Hospital 55 Fruit Street Boston,MA02114	04-2697983	501(c)(3)	212,441	BASIC RESEARCH
(62) Case Western Reserve University 10900 Euclid Ave Cleveland,OH44106	34-1018992	501(c)(3)	233,309	BASIC RESEARCH
(63) Vaccine & Gene Therapy Institute of Florida 9801 SW Discovery Way Pt St Lucie,FL34987	36-4631835	501(c)(3)	393,524	BASIC RESEARCH

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2013

Page 2

Part III

Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a)Type of grant or assistance	(b)Number of recipients	(c)Amount of cash grant	(d)Amount of non-cash assistance	(e)Method of valuation (book, FMV, appraisal, other)	(f)Description of non-cash assistance

Part IV

Supplemental Information. Provide the information required in Part I, line 2, Part III, column (b), and any other additional information.

Return Reference

Explanation

Grants and Assistance

Part I, Line 2 amfAR provides grants and fellowships to independent not-for-profit organizations through a peer-review process. Grant applications are first reviewed by the Foundation's volunteer scientific advisory committee, which comprises recognized experts in the medical, scientific, and social sciences disciplines relevant to HIV and AIDS. The scientific advisory committee then sends its evaluations to one of the three committees (research, global initiatives or public policy) of the Foundation's program board, which serves in an advisory capacity to the Board of Trustees. After a program committee has completed its review of the applications, it presents its funding recommendations to amfAR's executive committee and/or the full Board of Trustees for final approval and funding authorization. Grants and fellowships are payable over a one-to-three-year period, and are revocable at amfAR's option if the recipient's performance or use of funds is not consistent with the terms of the grant or fellowships. In certain cases, the actual amounts paid under grants and fellowship awards may be less than the original award if the recipient does not use the full amount awarded. Therefore, a reserve for unexpended grants and fellowships has been recorded. Subawards are grants awarded to not-for-profit organizations to support the costs of collaboration and participation in HIV/AIDS-related research projects for which amfAR has secured restricted funds. Subawards are payable over a one-year period, although advance payments, in full or in part, may be issued following execution of the subaward agreement. Subawards are contingent upon the availability of funds and are revocable if the recipients' performance or use of funds is not consistent with the subaward terms.

Schedule I (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" to Form 990, Part IV, line 23.
SchJMediumBullet

Attach to Form 990. SchJMediumBullet

See separate instructions.
SchJMediumBullet

Information about Schedule J (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? ................

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 5a or 5b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 6a or 6b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................

If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2013

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(1)Kevin FrostChief Executive Officer	(i) (ii)	374,093		37,373	94,850	45,331	551,647	37,373
(2)Bradley JensenAssistant Treasurer, Cfo	(i) (ii)	225,977			16,089	35,062	277,128
(3)John F Logan JD PhDAssT Sec, Vp, GEN COUNSEL	(i) (ii)	210,168			14,904	11,419	236,491
(4)Rowena JohnstonAsSt Secretary, Vice PresIDENT	(i) (ii)	173,783			12,205	11,419	197,407
(5)Edward DonnellyAsst Treasurer, ControlleR	(i) (ii)	139,447			10,188	10,476	160,111
(6)Eric MuscatellVice President of Development	(i) (ii)	164,114	0	0	11,727	11,419	187,260
(7)Christopher CollinsVice President, Public Policy	(i) (ii)	190,478			13,483	35,062	239,023
(8)Annette SohnVice President, TREAT Asia PGM	(i) (ii)	200,792			14,505	5,576	220,873
(9)AnnMarie ShannahanVice President, Public Info.	(i) (ii)	200,861			14,150	11,419	226,430
(10)Andrew McInnessDirector, Publications	(i) (ii)	142,695			10,271	35,062	188,028
(11)Anthony AnconaVice President, Human Resource	(i) (ii)	158,957			11,373	11,419	181,749
(12)Susan DosterChief Technology Officer	(i) (ii)	132,756			9,604	15,885	158,245
(13)Bennah SerfatySr Director of CommunicatiON	(i) (ii)	113,800			8,164	35,062	157,026
(14)Raoul Norman TenazasCreative Director	(i) (ii)	110,187			8,037	35,062	153,286
(15)GREGORY L BOROFFVP, DEVELOPMENT	(i) (ii)	155,189			11,017	6,632	172,838

Schedule J (Form 990) 2013

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.

Return Reference	Explanation
Compensation	Part I, Line 4 Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan. Amfar contributed $59,500 into Mr. Frost's non-qualified retirement plan; in additon mr. Frost received $37,373 distribution from the plan that is reported in column (b)(iii).

Schedule J (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE M
(Form 990)

Department of the Treasury

Internal Revenue Service

Noncash Contributions

Complete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image

Attach to Form 990.
Right pointing arrow large image

Information about Schedule M (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Types of Property

	(a) Check if applicable	(b) Number of contributions or items contributed	(c) Noncash contribution amounts reported on Form 990, Part VIII, line 1g	(d) Method of determining noncash contribution amounts
1 Art—Works of art ....
2 Art—Historical treasures .
3 Art—Fractional interests ..
4 Books and publications ..
5 Clothing and household goods .......
6 Cars and other vehicles ..
7 Boats and planes ....
8 Intellectual property ...
9 Securities—Publicly traded .	X	18	199,065	sales price
10 Securities—Closely held stock .
11 Securities—Partnership, LLC, or trust interests ....
12 Securities—Miscellaneous ..
13 Qualified conservation contribution—Historic structures .....
14 Qualified conservation contribution—Other ...
15 Real estate—Residential .
16 Real estate—Commercial ..
17 Real estate—Other ...
18 Collectibles .....
19 Food inventory ...
20 Drugs and medical supplies .
21 Taxidermy ......
22 Historical artifacts ....
23 Scientific specimens ..
24 Archeological artifacts ...
25 Other ( )
26 Other ( )
27 Other ( )
28 Other ( )

Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement ...

Yes

30a

During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that

it must hold for at least three years from the date of the initial contribution, and which is not required to be used

for exempt purposes for the entire holding period? ..................

30a

If "Yes," describe the arrangement in Part II.

Does the organization have a gift acceptance policy that requires the review of any non-standard contributions?

Yes

32a

Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash

contributions? ..........................

32a

If "Yes," describe in Part II.

If the organization did not report an amount in column (c) for a type of property for which column (a) is checked,

describe in Part II.

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 51227J

Schedule M (Form 990) (2013)

Page 2

Part II

Supplemental Information. Provide the information required by Part I, lines 30b,
32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.

Return Reference	Explanation
Form 990, Schedule M, line 31	To the extent that amFAR receives non-standard contributions, the organization's policy is to liquidate those items into cash for eventual use in support of the organization's mission.

Schedule M (Form 990) (2013)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Information about Schedule O (Form 990 or 990-EZ) and its instructions is at
www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Return Reference	Explanation
Program Service Accomplishments(1)	Part III, Line 4a-4d(1) Line 4a: Research: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. New Grants and Fellowships Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the treatment, prevention, and cure of HIV/AIDS. In FY2014, amfAR awarded nearly $7 million in grants and fellowships to support 34 research projects. Six researchers received Mathilde Krim Fellowships in Basic Biomedical Research, an initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The initiative has already achieved spectacular results, including numerous published studies in major scientific journals. The 2014 Krim Fellows-each of whom received $150,000-are working on projects focused on HIV/AIDS cure and epidemiological research and vaccine and treatment development. Among the 2014 fellows is Dr. Damien Tully of Massachusetts General Hospital, Cambridge, MA, who is using his amfAR funding to study tissue from mouse models and recently infected people to better understand how the virus spreads once infection occurs. HIV is usually transmitted through mucosal membranes, such as at the vagina or rectum, but eventually the virus wreaks its havoc in the intestines. Under the guidance of mentor Dr. Todd Allen, Dr. Tully aims to understand how the virus spreads and evolves in the body and to generate vital information for the development of a vaccine and possibly a cure. Cure-Focused Studies The search for a cure for HIV/AIDS is at the center of amfAR's research efforts. In FY2014, through the amfAR Research Consortium on HIV Eradication (ARCHE) program and other targeted grants, the Foundation awarded over $6 million toward cure-focused research. Countdown to a Cure for AIDS In February 2014, amfAR launched the Countdown to a Cure for AIDS, a research initiative aimed at developing the scientific basis for a cure for HIV by 2020. In support of the Countdown, amfAR plans to strategically invest $100 million in cure research over the next six years. amfAR Research Consortium on HIV Eradication The Foundation launched ARCHE in 2010 to encourage teams of distinguished scientists from across the globe to work collaboratively on cure-focused research and to provide them with the resources to do so. Since its inception, ARCHE funding has supported the work of 86 research teams pursuing cure-focused studies at 51 institutions on five continents. In July, more than $2.4 million in funding went to seven collaborative teams of researchers working in countries including the United States, the United Kingdom, the Netherlands, Finland, France, Germany, Spain, Sweden, Thailand, and Australia on studies exploring potential strategies for characterizing viral reservoirs-a major obstacle to a cure-and eliminating HIV infection from the body. The largest award in this round of grants is supporting a consortium of European researchers studying the outcomes of HIV patients who undergo different types of stem cell transplants. Timothy Brown, the first and only person known to have been cured of HIV, received a stem cell transplant from a donor with a rare genetic mutation conferring resistance to HIV infection. The research team, led by Dr. Javier Martinez-Picado of Irsi Caixa in Spain and Dr. Annemarie Wensing of University Medical Center Utrecht in the Netherlands, anticipate having several HIV patients in need of stem cell transplants and hope to generate new knowledge that can inform more widely applicable interventions. A team of researchers in the U.S. will receive funding to address one of the most pressing challenges in HIV research: determining whether people whose HIV has dropped to an undetectable level have been cured, or whether current tests are simply not sensitive enough to detect every last remnant of virus. In a recent amfAR-funded study, Dr. Timothy Henrich of Brigham and Women's Hospital in Boston described two patients who had received stem cell transplants to treat their cancer and in whom HIV could no longer be detected using the most sophisticated tests currently available. When the patients stopped taking antiretroviral therapy, their virus eventually returned, indicating that they had not been cured. Dr. Henrich is collaborating with Dr. Ramesh Akkina of Colorado State University in an effort to infuse cells taken from the Boston patients prior to viral rebound into mice engineered to contain human immune systems. If the mice become infected, this would represent a more sensitive test of HIV persistence than any other test currently available. Targeted Grants for HIV Cure Research In February 2014, amfAR awarded 12 targeted grants totaling more than $2.15 million to leading researchers from around the world who are working on a variety of cutting-edge, cure-focused studies. These projects include research aimed at therapeutic vaccine development, expanding our understanding of latent viral reservoirs, and examining pharmacological and gene therapy approaches to curing HIV. Dr. Nancy Haigwood and her colleagues at Oregon Health and Science University in Portland are testing the ability of antibodies to limit the establishment of the viral reservoir in newborns infected with HIV. In a study that could inform our understanding of how and when the reservoir is established, Dr. Haigwood's team is testing in infant macaques the effects of antibodies found to be effective in controlling HIV in humans. At the University of California, San Francisco, Dr. Hiroyu Hatano and colleagues are recruiting subjects from ongoing studies of PrEP (pre-exposure prophylaxis). Because these study participants are frequently tested for HIV, Dr. Hatano believes her team will be able to identify subjects in the first couple of weeks of infection, when the viral reservoirs are established. This will allow the researchers to discover which cells HIV infects at various stages during acute infection and how very early treatment might affect the size or distribution of the reservoir. A team of researchers at the University of Toronto led by Dr. Mario Ostrowski is pursuing an entirely different strategy: therapeutic vaccination. Dr. Ostrowski and colleagues are conducting a small pilot clinical trial of a therapeutic vaccine to determine whether it can reduce the size of the reservoir. The vaccine will be tested in subjects who started antiretroviral therapy within six months of acquiring HIV and is intended to induce cellular immunity, one arm of the immune system responsible for killing cells that are infected with the virus. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In the past year, at least 49 scientific publications resulted from amfAR-funded research. Killer Immunity and HIV Reservoirs In the January issue of the Journal of Acquired Immune Deficiency Syndromes, amfAR grantee Dr. Mathias Lichterfeld reported on the immune responses of "elite controllers," people infected with HIV but capable of maintaining low viral loads and high T cell counts without the aid of antiretroviral therapy. Dr. Lichterfeld, working at Harvard University and Massachusetts General Hospital, along with colleagues there and at China Medical University in Shenyang, focused on a major player in the T cell immune system: the CD8+ cytotoxic cell. These "killer T cells" are capable of destroying cells infected with viruses. The research team found that the CD8+ T cells' ability to kill HIV-infected cells was significantly greater in elite controllers than in patients requiring antiretroviral therapy to suppress virus. Of even greater interest, further studies showed a consistent relationship among a genetic marker called MHC-1 B57, high killer T cell activity, and low virus reservoir. In addition, the effect was most pronounced in nave T cells-a type of immune cell that constitutes the reservoir but has
Program Service Accomplishments (2)	Part III, Line 4a-4d (2) Line 4b: TREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 21 adult and 18 pediatric sites throughout the region, which collaborate on a variety of projects. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from approximately 9,000 patients at 21 clinical sites in 12 countries. The information gathered and analysed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. In FY2014, the TAHOD network launched a multi-site clinical study in Asia that addresses obstacles to treating hepatitis C among those co-infected with HIV in four countries: Indonesia, Malaysia, Thailand, and Vietnam. The study began with a screening to assess how many HIV-positive patients in TREAT Asia participating clinics in these countries needed to start treatment for hepatitis C. At the end of September, the study had enrolled approximately 135 patients in treatment, and will continue to enroll up to 200 patients. The study aims to develop a pilot model of care for treating hepatitis C in resource-limited settings that can be replicated throughout the region, where treatment for the disease is costly and often inaccessible. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. TREAT Asia Pediatric Network TREAT Asia's Pediatric Network includes 18 sites in six countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult database and includes data from approximately 5,500 pediatric patients at 18 clinical sites in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. In FY2014, the TREAT Asia Studies to Evaluate Resistance, Pediatrics (TASER-P) completed core activities of a three-year study on how children and adolescents who had developed resistance to first-line antiretrovirals (ARV) responded and adhered to second-line treatment. Ongoing analysis has provided insights into how to improve long-term ARV management in children and adolescents. TREAT Asia will continue to follow approximately 60 children who have developed resistance to second-line treatment for another two years in order to better understand which third-line ARVs will be most needed in the region. Adolescent Research In FY2014, TREAT Asia conducted several studies on how HIV affects adolescents physically, socially, and emotionally. TREAT Asia's pediatric sites conducted local studies among their adolescent HIV patients to investigate HIV's impact on their health and developmental needs. Among other issues, they investigated adolescents' reproductive and sexual health needs, liver function, treatment failure, treatment adherence, and the impact of orphanhood, disclosure, and school attendance on antiretroviral outcomes. In addition, TREAT Asia is conducting an ongoing study using an audio-computer-assisted survey instrument (ACASI) to better understand how adolescents experience living with HIV by allowing them to anonymously respond to questions using a computer interface about whether they are taking their medicines; if they have tried alcohol, tobacco, or other drugs; their sexual behavior; and stigma they may have experienced at school or at home. Exploring Links Between HIV and Cancer Among HIV-positive men who have sex with men (MSM), the risk of anal cancer is twice the level of those who are HIV-negative, but little research has been done on this issue in Asia. In 2009, using funding from IeDEA, TREAT Asia began supporting an innovative research study exploring the links between HIV and anal cancer and looking at cancer biomarkers in an attempt to better identify MSM with pre-cancerous anal lesions. Research on human papillomavirus (HPV) and anal cancer risk among MSM is ongoing at sites in Bangkok, Bali, and Jakarta. Building Research and Treatment Capacity TREAT Asia has implemented a research education program to help network members strengthen their skills in conducting clinical research and to boost the overall quality of care in the region. TREAT Asia organized 10 workshops and training sessions in FY2014, including sessions for health providers on managing HIV and hepatitis C co-infection, treating men who have sex with men, clinical management of pediatric HIV, rights and legal protections for women living with HIV, and communication skills to promote early HIV testing and treatment. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access Communicating treatment information about a disease as complex as HIV/AIDS can be daunting, but patients' lives depend on it. TREAT Asia works closely with regional organizations to support treatment literacy activities, including the production of "community-friendly" educational brochures on HIV treatment standards in local languages. In FY2014, TREAT Asia developed three fictional videos on the sexual and reproductive health and rights of women living with HIV that provide examples of both positive and negative advice that HIV-positive pregnant women might receive from healthcare professionals. The videos are in Thai and have English subtitles. They are available on TREAT Asia's webpage and its public YouTube channel. In addition, TREAT Asia released a policy brief titled Hepatitis C and HIV: Addressing the Dual Epidemic, which summarizes hepatitis C disease progression, treatment, and advocacy priorities. It also produced a fact sheet providing a summary of the key recommendations in the first World Health Organization guidelines on the screening, care, and treatment of persons with hepatitis C infection. TREAT Asia also held a regional meeting on improving access to hepatitis C treatment, which was attended by 20 advocates from six South and Southeast Asian countries. TREAT Asia also continued to publish lay-language articles on AIDS research, policy, and community issues facing the TREAT Asia network and the Asia-Pacific as a whole. The articles appear in the TREAT Asia Report, a bimonthly e-newsletter, and on TREAT Asia's website, www.treatasia.org. 20th International AIDS Conference TREAT Asia was well represented at the main and pre-conference events in July 2014 in Melbourne, Australia. TREAT Asia staff and network investigators participated in pre-conference workshops on HIV pediatric and HIV cure research. At the pediatric workshop, presentations were made on two TREAT Asia studies and one IeDEA multi-regional analysis (duration of initial antiretroviral therapy). At the main conference, additional TREAT Asia studies were presented on adherence to treatment and experiences of stigma among adolescents, hepatitis C co-infection and liver disease, and 10-year treatment outcomes in TREAT Asia's regional adult HIV cohort. Dr. Annette Sohn, amfAR vice president and director of the TREAT Asia program, was invited to give oral presentations on key at-risk populations in Asia, non-communicable diseases in resource-limited settings, and pediatric and adolescent HIV.
Program Service Accomplishments (3)	Part III, Line 4a-4d (3) Line 4c: EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 45,000 people; the TREAT Asia Report, an e-mail newsletter distributed six times a year to more than 4,000 readers in the international health community; and a monthly e-mail newsletter distributed to nearly 100,000 people. The Foundation's website features news, interviews, blog posts, and other original articles covering science, policy, the global epidemic, and amfAR programs and activities. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues, and conducts public service advertising campaigns that have been instrumental in educating policymakers, healthcare professionals, people living with HIV/AIDS, and the general public. Social Media amfAR vigorously expanded its presence in the social media arena, reaching large numbers of people, including a younger demographic that is often less educated about HIV and the AIDS epidemic. The Foundation regularly added content to its Facebook page and live tweeted and posted images on Instagram from fundraising and program events. amfAR has 57,000 likes on Facebook, 29,000 Twitter followers, and nearly 33,000 Instagram followers. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS-related press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR spokespeople-were carried in numerous media outlets, including the New York Times, The Wall Street Journal, The Washington Post, and The Huffington Post, and news agencies such as the Associated Press, CNN, Bloomberg News, and Reuters. amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. Support of amfAR by prominent public figures began with the late Dame Elizabeth Taylor, and others have followed in her footsteps. amfAR is profoundly grateful for the continuing steadfast support of Global Fundraising Chairman Sharon Stone. In FY2014, celebrity supporters included amfAR Ambassadors Cheyenne Jackson, Janet Jackson, Milla Jovovich, Liza Minnelli, and Michelle Yeoh, as well as Dame Shirley Bassey, Justin Bieber, Mary J. Blige, Jessica Chastain, Sofia Coppola, Alan Cumming, Willem Dafoe, Leonardo DiCaprio, Jane Fonda, Grace Jones, Heidi Klum, Julianna Margulies, Kylie Minogue, Aishwarya Rai and Abhishek Bachchan, Lana Del Rey, Michelle Rodriguez, Diana Ross, and Dita Von Teese, among many others.
Program Service Accomplishments (4)	Part III, Line 4a-4d (4) THE GMT INITIATIVE: Since 2007, amfAR has been serving the HIV-related needs of gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR helps expand access to HIV education and prevention services; supports advocacy aimed at increasing funding for prevention and treatment services; and works to end the stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS. Community Awards In FY2014, amfAR awarded approximately $300,000 to 15 groups in Africa and Latin America for a wide range of projects addressing HIV prevention, outreach, education, advocacy, testing, research, and capacity building. Sample funded projects include: Africa Alternatives-Cameroun (Douala, Cameroon) Alternatives used its fifth year of GMT Initiative support to integrate peer-led strategies with clinical services to increase LGBT individuals' access to HIV prevention, care, and treatment in Douala. Alternatives mobilized their peer educators across the city to hold discussions on HIV/AIDS and STI prevention and treatment, while also promoting the services at its Access Center to increase the patient roster. In addition to the comprehensive medical services offered at the Access Center, Alternatives offered mobile testing and organized testing awareness days to reach a broader number of LGBT through HIV testing. Action Humanitaire Pour la Sant et le Dveloppement Communautaire (AHUSADEC) (Bukavu, Democratic Republic of the Congo) In its second year of amfAR support, AHUSADEC improved its referral system for GMT-friendly public healthcare centers in Bukavu to improve the ability of GMT to access health services and HIV testing and treatment. It also empowered GMT sex workers by providing HIV prevention information. In addition, AHUSADEC hosted training workshops for healthcare workers at the GMT-friendly testing centers to ensure a stigma-free environment and launched a media campaign addressing HIV-related issues. Latin America Asociacin de Travestis, Transexuales, y Transgeneros de Argentina Asociacin Civil (ATTTA) (Buenos Aires, Argentina) ATTTA conducted a survey on attitudes, behaviors, and practices regarding sexual health and HIV prevention and risks for 180 transgender women and 40 of their stable partners in Buenos Aires, Argentina. The survey results were used to establish baseline behavioral data to inform policies and programs for transgender women. In addition, ATTTA established baseline HIV prevalence data by offering rapid HIV testing and counseling to all clients seeking services at their mobile health unit. The group also evaluated the acceptability of these services and referred all those with positive results directly to partner clinics. Red Nacional de Mujeres Travestis, Transexuales y Transgeneros de Bolivia (RED TREBOL) (Cochabamba, Bolivia) RED TREBOL used its third consecutive grant from amfAR to create the first trans-specific health center in Cochabamba. RED TREBOL established a physical space for the clinic and began to train peer educators to promote the clinic and its services and distribute referrals for the clinic to create demand. A medical team that provides services for RED TREBOL at their mobile unit program began offering HIV testing and counseling, hormones and hormonal guidance, STI prevention and treatment services, and mental health services at the clinic. "In Action" Awards Using two-year funding from the Arcus Foundation, the GMT Initiative supported four organizations as part of its Advocacy in Action program, which engages GMT-led community-based organizations that wish to influence the policies of governments and external donors. Ten organizations were supported through its Evidence in Action program, which documents and evaluates the impact of community-based programs with the ultimate goal of implementing the most workable strategies for stopping the spread of HIV/AIDS. Evidence in Action was developed with support from ViiV Healthcare's Positive Action Program and the Elton John AIDS Foundation. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations about the spread of HIV among GMT individuals and to advocate for effective strategies to address it, amfAR publishes reports on HIV and GMT. In FY2014, the GMT Initiative published two reports in its "Lessons from the Front Lines" series. The first, Lessons From the Front Lines: Research Impact Analysis, outlined some of the most successful community-led research studies GMT grantee partners have implemented to improve HIV testing, treatment, and awareness in five regions-Africa, Asia-Pacific, the Caribbean, Eastern Europe and Central Asia, and Latin America. The second, Lessons From the Front Lines: Trans Health and Rights, produced in collaboration with Global Action for Trans Equality (GATE), examined the challenges faced by 10 grantee partners-many of which were led by transgender individuals-and assessed their progress. The GMT Initiative also created a series of fact sheets in English, French, and Spanish on emerging HIV prevention technologies that explain each technology and serve as a tool to help GMT advocates advocate for the interventions' increased availability worldwide. Symposia and Conferences In January 2014, the GMT Initiative supported and attended a meeting hosted by the University of West Indies (UWI) and Columbia University engaging GMT community organization grantee partners, researchers, government officials, and other key stakeholders to develop a formalized GMT-related research agenda for Jamaica. Based on a similar program amfAR funded in South Africa, UWI and Columbia University used the meeting to formulate a research plan for submission to the U.S. National Institutes of Health for funding. In May, amfAR partnered with the Gay and Lesbian Coalition of Kenya (GALCK) and the International AIDS Vaccine Initiative (IAVI) to sponsor a meeting between LGBT community members and social/behavioral researchers in Kenya to formulate a community-led research agenda on LGBT health. The GMT Initiative played an active role at the 2014 International AIDS Conference and the MSM pre-conference in Melbourne, Australia. Eighteen GMT activists and grantee partners received support from amfAR to attend the conference. All had at least one presentation during the conference, with many speaking on multiple panels and poster sessions. GMT Initiative staff convened nine sessions on topics including the results and lessons learned from its Evidence in Action program, transgender health and rights, information and communication technology use in HIV efforts targeting GMT individuals, lubricant access, and safety and security in conducting HIV research with GMT in rights-constrained settings. In addition, the GMT Initiative hosted a donor meeting on transgender issues and a grantee exchange meeting (in conjunction with the Public Policy office) for 24 representatives from current grantee partners.
Program Service Accomplishments (5)	Part III, Line 4a-4d (5) public policy: Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the U.S. National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Capitol Hill Briefings The Role of HIV Research in Ending AIDS: New Developments in HIV Vaccine and Prevention Science, November 18, 2013 amfAR co-sponsored this briefing with AVAC: Global Advocacy for HIV Prevention, the Center for Global Health Policy, and the International AIDS Vaccine Initiative, in cooperation with Congresswoman Barbara Lee. Speakers included Carl Dieffenbach, director of NIAID's Division of AIDS; Fred Sawe, deputy director of Kenya Medical Research Institute/Walter Reed Project; Christina Polyak, research physician at the Military HIV Research Program, Walter Reed Army Institute of Research; and Margaret McGlynn, president and chief executive officer of the International AIDS Vaccine Initiative. Christine Lubinski, executive director of the Center for Global Health Policy, and Kevin Fisher, policy director of AVAC: Global Advocacy for HIV Prevention, acted as moderators. Making AIDS History: From Science to Solutions, April 30, 2014 amfAR convened a panel of leading government, research, policy, and advocacy experts in Washington, D.C., to discuss recent progress in the fight against HIV/AIDS, both domestically and globally. Participants included Dr. Jim Yong Kim, president of the World Bank Group; Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; Dr. Deborah Birx, Ambassador-at-Large and U.S. Global AIDS Coordinator; Michel Sidib, executive director of UNAIDS; Judy Woodruff, co-anchor of PBS NewsHour; Dr. Paul Farmer, co-founder of Partners in Health and chair of Harvard Medical School's Department of Global Health and Social Medicine; and Douglas Brooks, director of the White House Office of National AIDS Policy; among others. Members of Congress, including House Democratic Leader Nancy Pelosi, Senator Tom Harkin, and Congressman Jim Himes, also spoke at the briefing organized by Dr. Susan Blumenthal, amfAR's senior policy and medical advisor and former U.S. Assistant Surgeon General. Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the epidemic in the U.S., where more than 1 million people are living with the virus. In FY2014, amfAR produced a number of opinion pieces, issue briefs, special reports, and infographics addressing important domestic topics, such as funding for AIDS research and U.S. HIV/AIDS programs, Medicaid expansion's effect on HIV health services in the U.S., and HIV prevention among key populations, specifically transgender individuals and black MSM. In December 2013, amfAR partnered with the Treatment Action Group (TAG) to issue a report titled Filling the Gaps in the U.S. HIV Treatment Cascade: Developing a Community Driven Research Agenda that outlined research needed to improve outcomes on the domestic HIV treatment cascade and ensure more people are engaged and retained in HIV care. The two groups then jointly held a series of meetings with government officials on next steps to enact the agenda. As one of the earliest supporters of comprehensive harm reduction programs for people who inject drugs (PWID), including syringe exchange, amfAR has played a leading role in advocating the implementation of these lifesaving HIV prevention programs. In FY2014, amfAR continued to advocate overturning the ban on federal funding of syringe services programs. Global Health amfAR produced a special report with AVAC: Global Advocacy for HIV Prevention outlining the need for a new approach to tracking data to guide the key decisions that shape the global response to the HIV/AIDS epidemic. The report, titled Data Watch: Closing a Persistent Gap in the AIDS Response, updates amfAR's and AVAC's 2012 Action Agenda to End AIDS, which made the case for a more businesslike approach to ending the epidemic and proposed a multi-year plan with concrete strategies, targets, and timelines. amfAR also partnered with AVAC to place an opinion piece written by Chris Collins, former amfAR vice president and director of Public Policy, and Mitchell Warren, executive director of AVAC, titled "Time to Tip the Scales in Favor of Ending AIDS" in the Huffington Post to accompany the report. The editorial was also posted on POZ.com and the Kaiser Daily Summary. Additionally, in FY2014, amfAR reported on the need for funding for the global AIDS response through opinion pieces, issue briefs, and infographics, with specific attention to how funding cuts to the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria would undermine a decade's worth of progress in scaling up treatment and care. In January 2014, Dr. Susan Blumenthal, amfAR senior policy and medical advisor, placed an opinion piece in the Huffington Post titled "Our Shared Responsibility: Ending AIDS, Tuberculosis, and Malaria." Public Policy also continued to advocate for sound, evidence-based policies to address HIV among key populations globally. In FY2014, Kali Lindsey, deputy director of the Public Policy Office, traveled to Kenya and Vietnam to discuss efforts to scale up access to syringe exchange, methadone, and ARV for PWID. Gay men, other men who have sex with men, and transgender individuals-collectively referred to as GMT-remain one of the hardest hit and most underserved populations in the global HIV/AIDS epidemic. amfAR's policy office works closely with the Foundation's GMT Initiative to advocate for expanded access to HIV prevention and treatment services for GMT worldwide, and to fight the stigma and discrimination that make GMT more vulnerable to HIV infection and inhibit equal access to care. In March, amfAR Founding Chairman Dr. Mathilde Krim and amfAR Trustee Harry Belafonte expressed their grave concern over new anti-LGBT laws in Uganda and Nigeria in an opinion piece for CNN.com.
Policies	form 990, part vi, section b Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. LINE 15 -AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS.
Disclosure	Form 990, Part VI, Section C LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion.
Functional Expenses	Part IX, Lines 1 & 3 The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F.
Other Changes in Net Assets	FORM 990, SECTION XI, LINE 5 CHANGE IN VALUE OF THIRD PARTY TRUST............($33,603) --------- TOTAL LINE 9 ($33,603)

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

1	Briefly describe the organization’s mission or most significant activities: amfar is dedicated to ending the global AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	20
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	20
5	Total number of individuals employed in calendar year 2013 (Part V, line 2a) ......	5	92
6	Total number of volunteers (estimate if necessary) .............	6	160
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	38,582,579	57,556,516
9	Program service revenue (Part VIII, line 2g) .........	0	0
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	980,398	1,225,465
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	-9,648,345	-10,881,866
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)...................	29,914,632	47,900,115
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	7,997,283	9,928,384
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	9,333,804	9,582,859
16a	Professional fundraising fees (Part IX, column (A), line 11e).....	470,337	569,004
b	Total fundraising expenses (Part IX, column (D), line 25) 5,153,653
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	11,457,241	14,312,877
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	29,258,665	34,393,124
19	Revenue less expenses. Subtract line 18 from line 12.......	655,967	13,506,991
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	50,024,337	57,895,971
21	Total liabilities (Part X, line 26).............	18,892,314	13,585,624
22	Net assets or fund balances. Subtract line 21 from line 20.....	31,132,023	44,310,347

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 11,765,284 including grants of $ 5,482,076 ) (Revenue $ 0 )
	RESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the National Institutes of Health. FOR FURTHER DETAILS, SEE SCHEDULE O.

4b	(Code: ) (Expenses $ 6,754,069 including grants of $ 3,275,924 ) (Revenue $ 0 )
	TREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) involves a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 21 adult and 18 pediatric sites throughout the region, which collaborate on a variety of projects. FOR FURTHER DETAILS, SEE SCHEDULE O.

4c	(Code: ) (Expenses $ 3,625,752 including grants of $ 0 ) (Revenue $ 0 )
	EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research on HIV/AIDS. FOR FURTHER DETAILS, SEE SCHEDULE O.

	(Code: ) (Expenses $ 2,388,396 including grants of $ 875,445 ) (Revenue $ 0 )
	GMT Initiative

	(Code: ) (Expenses $ 2,233,490 including grants of $ 294,939 ) (Revenue $ 0 )
	public policy

4d	Other program services (Describe in Schedule O.)
	(Expenses $ 4,621,886 including grants of $ 1,170,384 ) (Revenue $ 0 )
4e	Total program service expenses26,766,991

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)		(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(1) Mathilde Krim PhD........................................................................ Founding Chairman	1.0 .......................	X	X	0	0	0
(2) Kenneth Cole........................................................................ Chairman of the Board	1.0 .......................	X	X	0	0	0
(3) Patricia J Matson........................................................................ Vice Chairman	1.0 .......................	X	X
(4) John C Simons........................................................................ Vice Chairman	1.0 .......................	X	X
(5) Wallace Sheft CPA........................................................................ Treasurer	1.0 .......................	X	X
(6) Mervyn F Silverman MDMPH........................................................................ Secretary	1.0 .......................	X	X
(7) Arlen H Andelson........................................................................ Trustee	1.0 .......................	X
(8) Harry Belafonte........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(9) David Bohnett........................................................................ Trustee	1.0 .......................	X
(10) Zev Braun........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(11) Jonathan S Canno........................................................................ Trustee	1.0 .......................	X
(12) Donald Capoccia........................................................................ Trustee	1.0 .......................	X
(13) R Martin Chavez PhD........................................................................ Trustee	1.0 .......................	X
(14) Jane B Eisner........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(15) T Ryan Greenawalt........................................................................ Trustee	1.0 .......................	X
(16) Regan Hofmann........................................................................ Trustee	1.0 .......................	X
(17) Michael J Klingensmith........................................................................ Trustee	1.0 .......................	X

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)					(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(18) Kevin McClatchy........................................................................ Trustee	1.0 .......................	X
(19) Michele V McNeill PharmD........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(20) Edward Milstein........................................................................ Trustee	1.0 .......................	X
(21) Cindy Rachofsky........................................................................ Trustee	1.0 .......................	X
(22) Vincent A Roberti........................................................................ Trustee	1.0 .......................	X
(23) Bill Roedy........................................................................ Trustee	1.0 .......................	X
(24) Raymond F Schinazi PhD........................................................................ Trustee	1.0 .......................	X
(25) Alan D Schwartz........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(26) Diana L Taylor........................................................................ Trustee (NON-VOTING)	1.0 .......................	X					0	0	0
(27) Kevin Wendle........................................................................ Trustee (NON-VOTING)	1.0 .......................	X
(28) Kevin Frost........................................................................ Chief Executive Officer	40.0 .......................		X				411,466		140,181
(29) Bradley Jensen........................................................................ Assistant Treasurer, Cfo	40.0 .......................		X				225,977		51,151
(30) John F Logan JD PhD........................................................................ AssT Sec, Vp, GEN COUNSEL	40.0 .......................		X				210,168		26,323
(31) Rowena Johnston........................................................................ AsSt Secretary, Vice PresIDENT	40.0 .......................		X				173,783		23,624
(32) Edward Donnelly........................................................................ Asst Treasurer, ControlleR	40.0 .......................		X				139,447		20,664
(33) Eric Muscatell........................................................................ Vice President of Development	40.0 .......................			X			164,114		23,146
(34) Christopher Collins........................................................................ Vice President, Public Policy	40.0 .......................			X			190,478		48,545
(35) Annette Sohn........................................................................ Vice President, TREAT Asia PGM	40.0 .......................			X			200,792		20,081
(36) AnnMarie Shannahan........................................................................ Vice President, Public Info.	40.0 .......................			X			200,861		25,569
(37) Andrew McInness........................................................................ Director, Publications	40.0 .......................				X		142,695		45,333
(38) Anthony Ancona........................................................................ Vice President, Human Resource	40.0 .......................				X		158,957		22,792
(39) Susan Doster........................................................................ Chief Technology Officer	40.0 .......................				X		132,756		25,489
(40) Bennah Serfaty........................................................................ Sr Director of CommunicatiON	40.0 .......................				X		113,800		43,226
(41) Raoul Norman Tenazas........................................................................ Creative Director	40.0 .......................				X		110,187		43,099
(42) GREGORY L BOROFF........................................................................ VP, DEVELOPMENT	40.0 .......................					X	155,189		17,649

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)............	2,730,670	0	576,872

				(A) Total revenue	(B) Related or exempt function revenue	(C) Unrelated business revenue	(D) Revenue excluded from tax under sections 512-514
1a	Federated campaigns..1a		376,242
b	Membership dues....1b
c	Fundraising events....1c		39,937,861
d	Related organizations...1d
e	Government grants (contributions)1e		7,391,835

f	All other contributions, gifts, grants, and similar amounts not included above1f		9,850,578

g	Noncash contributions included in lines 1a-1f:$		199,065
h	Total. Add lines 1a-1f.......			57,556,516
			Business Code
2a
b
c
d
e
f	All other program service revenue .
g	Total. Add lines 2a–2f........			0
3	Investment income (including dividends, interest, and other similar amounts).......			740,190			740,190
4	Income from investment of tax-exempt bond proceeds..			0
5	Royalties...........			64,176			64,176
		(i) Real	(ii) Personal
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)	0	0
d	Net rental income or (loss).......			0
		(i) Securities	(ii) Other
7a	Gross amount from sales of assets other than inventory	17,316,472
b	Less: cost or other basis and sales expenses	16,831,197
c	Gain or (loss)	485,275
d	Net gain or (loss)..........			485,275			485,275
8a	Gross income from fundraising events (not including $ 39,937,861 of contributions reported on line 1c). See Part IV, line 18 ..
	a		1,448,865
b	Less: direct expenses ...b		12,639,445
c	Net income or (loss) from fundraising events..			-11,190,580			-11,190,580
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a
b	Less: direct expenses ...b
c	Net income or (loss) from gaming activities...			0
10a	Gross sales of inventory, less returns and allowances .
	a		239,927
b	Less: cost of goods sold ..b
c	Net income or (loss) from sales of inventory..			239,927			239,927
Miscellaneous Revenue			Business Code
11a	LIST RENTALS		900099	3,116			3,116
b	MISCELLANEOUS INCOME		900099	1,495			1,495
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......			4,611
12	Total revenue. See Instructions......			47,900,115			-9,656,401


				(A) Beginning of year		(B) End of year
1	Cash–non-interest-bearing .............			8,001,602	1	4,961,745
2	Savings and temporary cash investments .........			539,347	2	323,338
3	Pledges and grants receivable, net ...........			205,706	3	0
4	Accounts receivable, net .............			10,267,012	4	5,045,656
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
				0	5	0
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
				0	6	0
7	Notes and loans receivable, net .............			0	7	0
8	Inventories for sale or use ..............			133,906	8	213,295
9	Prepaid expenses and deferred charges ..........			1,401,620	9	1,475,828
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	5,731,579
b	Less: accumulated depreciation .....	10b	3,500,879	1,975,311	10c	2,230,700
11	Investments—publicly traded securities ..........			23,656,458	11	40,982,916
12	Investments—other securities. See Part IV, line 11 .....			3,169,232	12	2,101,105
13	Investments—program-related. See Part IV, line 11 .....			0	13	0
14	Intangible assets ...............			0	14	0
15	Other assets. See Part IV, line 11 ...........			674,143	15	561,388
16	Total assets. Add lines 1 through 15 (must equal line 34)......			50,024,337	16	57,895,971
17	Accounts payable and accrued expenses .........			1,688,090	17	2,132,495
18	Grants payable .................			2,200,512	18	2,547,120
19	Deferred revenue ................			13,321,993	19	7,166,426
20	Tax-exempt bond liabilities .............			0	20	0
21	Escrow or custodial account liability. Complete Part IV of Schedule D..			0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........			0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..			0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....			0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................			1,681,719	25	1,739,583
26	Total liabilities. Add lines 17 through 25.........			18,892,314	26	13,585,624
	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............			23,555,115	27	38,819,754
28	Temporarily restricted net assets ...........			7,236,209	28	5,143,351
29	Permanently restricted net assets ...........			340,699	29	347,242
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........				30
31	Paid-in or capital surplus, or land, building or equipment fund .....				31
32	Retained earnings, endowment, accumulated income, or other funds				32
33	Total net assets or fund balances ...........			31,132,023	33	44,310,347
34	Total liabilities and net assets/fund balances ........			50,024,337	34	57,895,971

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A).......................................	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)...............................................	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713)................................................	Yes	No